Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population
The comparative efficacy of the three mumps vaccine strains (Jeryl–Lynn, Urabe and Rubini) was conducted in an Asian population from data arising from an epidemiological investigation of seven institutional outbreaks of mumps in Singapore. Demographic information (gender, age, ethnic group), clinica...
Gespeichert in:
| Veröffentlicht in: | The Journal of infection 2005-11, Vol.51 (4), p.294-298 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 298 |
|---|---|
| container_issue | 4 |
| container_start_page | 294 |
| container_title | The Journal of infection |
| container_volume | 51 |
| creator | Ong, Gary Goh, Kee Tai Ma, Stefan Chew, Suok Kai |
| description | The comparative efficacy of the three mumps vaccine strains (Jeryl–Lynn, Urabe and Rubini) was conducted in an Asian population from data arising from an epidemiological investigation of seven institutional outbreaks of mumps in Singapore.
Demographic information (gender, age, ethnic group), clinical presentation and vaccination history (date and place of mumps vaccination, type of mumps vaccine received) of all children who attended the six childcare centres and one primary school where outbreaks of 20 or more cases of mumps occurred in 1999 were collected. The attack rate of the unvaccinated group and the attack rates of the vaccine groups (for each vaccine strain) were determined and the vaccine efficacy of the three vaccines calculated.
The vaccine efficacy of the Jeryl–Lynn strain, Urabe strain and Rubini strain mumps vaccine were 80.7, 54.4 and −55.3%, respectively.
Rubini strain mumps vaccine conferred no protection and has since been deregistered in Singapore. |
| doi_str_mv | 10.1016/j.jinf.2004.10.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68804542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445304002373</els_id><sourcerecordid>20853743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-abd4f7fdecb46a114b71fc18105791266367534686c9f7c69915038c71724d293</originalsourceid><addsrcrecordid>eNqFkM-KFDEQh4Mo7uzqC3iQXPRkz-ZfJ2nwsgy6KgML4p48hHS6Ahm6020yPTC3fQffcJ9k08zA3vRSBVVf_Sg-hN5RsqaEyuvdeheiXzNCRBmsCaEv0IrWnFVMCfYSrQrEKyFqfoEuc94RQhreyNfogkrWUKbZCv3ejMNkk92HA2DwPjjrjnj0-Ofchhg-4R-Qjv3jw9_tMUZsY4fvk20BD_MwZXywzoUIOCwrfJNDqdM4zX3JG-Mb9MrbPsPbc79C91-__Np8q7Z3t983N9vKCU33lW074ZXvwLVCWkpFq6h3VFNSq_KllFyqmguppWu8crJpaE24dooqJjrW8Cv08ZQ7pfHPDHlvhpAd9L2NMM7ZSK2JqAX7L8iIrrkSvIDsBLo05pzAmymFwaajocQs7s3OLO7N4n6ZFffl6P05fW4H6J5PzrIL8OEM2Oxs75ONLuRnTjGlBasL9_nEQZF2CJBMdgGigy4kcHvTjeFffzwBCWqhaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20853743</pqid></control><display><type>article</type><title>Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ong, Gary ; Goh, Kee Tai ; Ma, Stefan ; Chew, Suok Kai</creator><creatorcontrib>Ong, Gary ; Goh, Kee Tai ; Ma, Stefan ; Chew, Suok Kai</creatorcontrib><description>The comparative efficacy of the three mumps vaccine strains (Jeryl–Lynn, Urabe and Rubini) was conducted in an Asian population from data arising from an epidemiological investigation of seven institutional outbreaks of mumps in Singapore.
Demographic information (gender, age, ethnic group), clinical presentation and vaccination history (date and place of mumps vaccination, type of mumps vaccine received) of all children who attended the six childcare centres and one primary school where outbreaks of 20 or more cases of mumps occurred in 1999 were collected. The attack rate of the unvaccinated group and the attack rates of the vaccine groups (for each vaccine strain) were determined and the vaccine efficacy of the three vaccines calculated.
The vaccine efficacy of the Jeryl–Lynn strain, Urabe strain and Rubini strain mumps vaccine were 80.7, 54.4 and −55.3%, respectively.
Rubini strain mumps vaccine conferred no protection and has since been deregistered in Singapore.</description><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2004.10.001</identifier><identifier>PMID: 16291282</identifier><identifier>CODEN: JINFD2</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Child ; Child, Preschool ; Disease Outbreaks - prevention & control ; General aspects ; Human viral diseases ; Humans ; Infectious diseases ; Jeryl–Lynn strain ; Measles-Mumps-Rubella Vaccine - administration & dosage ; Measles-Mumps-Rubella Vaccine - immunology ; Measles-Mumps-Rubella Vaccine - standards ; Medical sciences ; Mumps ; Mumps - epidemiology ; Mumps - prevention & control ; Mumps - virology ; Mumps Vaccine - immunology ; Mumps Vaccine - standards ; Mumps virus - classification ; Mumps virus - immunology ; Rubini strain ; Sentinel Surveillance ; Serotyping ; Singapore - epidemiology ; Time Factors ; Treatment Outcome ; Urabe strain ; Vaccine efficacy ; Vaccines, Combined - immunology ; Vaccines, Combined - standards ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases</subject><ispartof>The Journal of infection, 2005-11, Vol.51 (4), p.294-298</ispartof><rights>2004 The British Infection Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-abd4f7fdecb46a114b71fc18105791266367534686c9f7c69915038c71724d293</citedby><cites>FETCH-LOGICAL-c481t-abd4f7fdecb46a114b71fc18105791266367534686c9f7c69915038c71724d293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0163445304002373$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17278425$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16291282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ong, Gary</creatorcontrib><creatorcontrib>Goh, Kee Tai</creatorcontrib><creatorcontrib>Ma, Stefan</creatorcontrib><creatorcontrib>Chew, Suok Kai</creatorcontrib><title>Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><description>The comparative efficacy of the three mumps vaccine strains (Jeryl–Lynn, Urabe and Rubini) was conducted in an Asian population from data arising from an epidemiological investigation of seven institutional outbreaks of mumps in Singapore.
Demographic information (gender, age, ethnic group), clinical presentation and vaccination history (date and place of mumps vaccination, type of mumps vaccine received) of all children who attended the six childcare centres and one primary school where outbreaks of 20 or more cases of mumps occurred in 1999 were collected. The attack rate of the unvaccinated group and the attack rates of the vaccine groups (for each vaccine strain) were determined and the vaccine efficacy of the three vaccines calculated.
The vaccine efficacy of the Jeryl–Lynn strain, Urabe strain and Rubini strain mumps vaccine were 80.7, 54.4 and −55.3%, respectively.
Rubini strain mumps vaccine conferred no protection and has since been deregistered in Singapore.</description><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Disease Outbreaks - prevention & control</subject><subject>General aspects</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Jeryl–Lynn strain</subject><subject>Measles-Mumps-Rubella Vaccine - administration & dosage</subject><subject>Measles-Mumps-Rubella Vaccine - immunology</subject><subject>Measles-Mumps-Rubella Vaccine - standards</subject><subject>Medical sciences</subject><subject>Mumps</subject><subject>Mumps - epidemiology</subject><subject>Mumps - prevention & control</subject><subject>Mumps - virology</subject><subject>Mumps Vaccine - immunology</subject><subject>Mumps Vaccine - standards</subject><subject>Mumps virus - classification</subject><subject>Mumps virus - immunology</subject><subject>Rubini strain</subject><subject>Sentinel Surveillance</subject><subject>Serotyping</subject><subject>Singapore - epidemiology</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Urabe strain</subject><subject>Vaccine efficacy</subject><subject>Vaccines, Combined - immunology</subject><subject>Vaccines, Combined - standards</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM-KFDEQh4Mo7uzqC3iQXPRkz-ZfJ2nwsgy6KgML4p48hHS6Ahm6020yPTC3fQffcJ9k08zA3vRSBVVf_Sg-hN5RsqaEyuvdeheiXzNCRBmsCaEv0IrWnFVMCfYSrQrEKyFqfoEuc94RQhreyNfogkrWUKbZCv3ejMNkk92HA2DwPjjrjnj0-Ofchhg-4R-Qjv3jw9_tMUZsY4fvk20BD_MwZXywzoUIOCwrfJNDqdM4zX3JG-Mb9MrbPsPbc79C91-__Np8q7Z3t983N9vKCU33lW074ZXvwLVCWkpFq6h3VFNSq_KllFyqmguppWu8crJpaE24dooqJjrW8Cv08ZQ7pfHPDHlvhpAd9L2NMM7ZSK2JqAX7L8iIrrkSvIDsBLo05pzAmymFwaajocQs7s3OLO7N4n6ZFffl6P05fW4H6J5PzrIL8OEM2Oxs75ONLuRnTjGlBasL9_nEQZF2CJBMdgGigy4kcHvTjeFffzwBCWqhaA</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Ong, Gary</creator><creator>Goh, Kee Tai</creator><creator>Ma, Stefan</creator><creator>Chew, Suok Kai</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population</title><author>Ong, Gary ; Goh, Kee Tai ; Ma, Stefan ; Chew, Suok Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-abd4f7fdecb46a114b71fc18105791266367534686c9f7c69915038c71724d293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Disease Outbreaks - prevention & control</topic><topic>General aspects</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Jeryl–Lynn strain</topic><topic>Measles-Mumps-Rubella Vaccine - administration & dosage</topic><topic>Measles-Mumps-Rubella Vaccine - immunology</topic><topic>Measles-Mumps-Rubella Vaccine - standards</topic><topic>Medical sciences</topic><topic>Mumps</topic><topic>Mumps - epidemiology</topic><topic>Mumps - prevention & control</topic><topic>Mumps - virology</topic><topic>Mumps Vaccine - immunology</topic><topic>Mumps Vaccine - standards</topic><topic>Mumps virus - classification</topic><topic>Mumps virus - immunology</topic><topic>Rubini strain</topic><topic>Sentinel Surveillance</topic><topic>Serotyping</topic><topic>Singapore - epidemiology</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Urabe strain</topic><topic>Vaccine efficacy</topic><topic>Vaccines, Combined - immunology</topic><topic>Vaccines, Combined - standards</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ong, Gary</creatorcontrib><creatorcontrib>Goh, Kee Tai</creatorcontrib><creatorcontrib>Ma, Stefan</creatorcontrib><creatorcontrib>Chew, Suok Kai</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ong, Gary</au><au>Goh, Kee Tai</au><au>Ma, Stefan</au><au>Chew, Suok Kai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>51</volume><issue>4</issue><spage>294</spage><epage>298</epage><pages>294-298</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><coden>JINFD2</coden><abstract>The comparative efficacy of the three mumps vaccine strains (Jeryl–Lynn, Urabe and Rubini) was conducted in an Asian population from data arising from an epidemiological investigation of seven institutional outbreaks of mumps in Singapore.
Demographic information (gender, age, ethnic group), clinical presentation and vaccination history (date and place of mumps vaccination, type of mumps vaccine received) of all children who attended the six childcare centres and one primary school where outbreaks of 20 or more cases of mumps occurred in 1999 were collected. The attack rate of the unvaccinated group and the attack rates of the vaccine groups (for each vaccine strain) were determined and the vaccine efficacy of the three vaccines calculated.
The vaccine efficacy of the Jeryl–Lynn strain, Urabe strain and Rubini strain mumps vaccine were 80.7, 54.4 and −55.3%, respectively.
Rubini strain mumps vaccine conferred no protection and has since been deregistered in Singapore.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>16291282</pmid><doi>10.1016/j.jinf.2004.10.001</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0163-4453 |
| ispartof | The Journal of infection, 2005-11, Vol.51 (4), p.294-298 |
| issn | 0163-4453 1532-2742 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68804542 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Biological and medical sciences Child Child, Preschool Disease Outbreaks - prevention & control General aspects Human viral diseases Humans Infectious diseases Jeryl–Lynn strain Measles-Mumps-Rubella Vaccine - administration & dosage Measles-Mumps-Rubella Vaccine - immunology Measles-Mumps-Rubella Vaccine - standards Medical sciences Mumps Mumps - epidemiology Mumps - prevention & control Mumps - virology Mumps Vaccine - immunology Mumps Vaccine - standards Mumps virus - classification Mumps virus - immunology Rubini strain Sentinel Surveillance Serotyping Singapore - epidemiology Time Factors Treatment Outcome Urabe strain Vaccine efficacy Vaccines, Combined - immunology Vaccines, Combined - standards Viral diseases Viral diseases of the respiratory system and ent viral diseases |
| title | Comparative efficacy of Rubini, Jeryl–Lynn and Urabe mumps vaccine in an Asian population |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A44%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20efficacy%20of%20Rubini,%20Jeryl%E2%80%93Lynn%20and%20Urabe%20mumps%20vaccine%20in%20an%20Asian%20population&rft.jtitle=The%20Journal%20of%20infection&rft.au=Ong,%20Gary&rft.date=2005-11-01&rft.volume=51&rft.issue=4&rft.spage=294&rft.epage=298&rft.pages=294-298&rft.issn=0163-4453&rft.eissn=1532-2742&rft.coden=JINFD2&rft_id=info:doi/10.1016/j.jinf.2004.10.001&rft_dat=%3Cproquest_cross%3E20853743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20853743&rft_id=info:pmid/16291282&rft_els_id=S0163445304002373&rfr_iscdi=true |